Insufficient scRNA-seq data for expression of GPHA2 at single-cell level.
Insufficient scRNA-seq data for expression of GPHA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1211.62 | 328 / 328 | 34% | 5.28 | 60 / 178 |
ovary | 89% | 38.67 | 160 / 180 | 44% | 1.18 | 191 / 430 |
prostate | 90% | 23.28 | 220 / 245 | 24% | 0.64 | 119 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.13 | 1 / 1 |
kidney | 83% | 19.52 | 74 / 89 | 14% | 0.34 | 125 / 901 |
spleen | 88% | 19.77 | 213 / 241 | 0% | 0 | 0 / 0 |
uterus | 42% | 7.20 | 72 / 170 | 36% | 2.98 | 167 / 459 |
stomach | 72% | 19.58 | 259 / 359 | 6% | 0.35 | 18 / 286 |
thymus | 73% | 10.04 | 477 / 653 | 3% | 0.04 | 17 / 605 |
liver | 62% | 9.93 | 141 / 226 | 4% | 0.12 | 18 / 406 |
lung | 56% | 8.11 | 324 / 578 | 10% | 0.35 | 119 / 1155 |
brain | 46% | 8.29 | 1214 / 2642 | 1% | 0.03 | 10 / 705 |
skin | 36% | 3.66 | 653 / 1809 | 1% | 0.02 | 4 / 472 |
intestine | 32% | 5.23 | 306 / 966 | 4% | 0.20 | 21 / 527 |
blood vessel | 34% | 18.76 | 450 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 1.43 | 14 / 45 |
breast | 23% | 2.77 | 107 / 459 | 5% | 0.16 | 61 / 1118 |
bladder | 24% | 1.90 | 5 / 21 | 4% | 0.22 | 22 / 504 |
adrenal gland | 21% | 2.90 | 55 / 258 | 2% | 0.05 | 4 / 230 |
esophagus | 13% | 1.14 | 187 / 1445 | 4% | 0.09 | 8 / 183 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.55 | 5 / 29 |
peripheral blood | 16% | 1.66 | 148 / 929 | 0% | 0 | 0 / 0 |
adipose | 8% | 1.04 | 97 / 1204 | 0% | 0 | 0 / 0 |
heart | 6% | 0.65 | 49 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
muscle | 2% | 0.24 | 19 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005179 | Molecular function | hormone activity |
GO_0031531 | Molecular function | thyrotropin-releasing hormone receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GPHA2 |
Protein name | Glycoprotein hormone subunit alpha 2 Glycoprotein hormone alpha 2, isoform CRA_a (Glycoprotein-alpha 2) Glycoprotein hormone alpha-2 (Putative secreted protein Zsig51) (Thyrostimulin subunit alpha) |
Synonyms | hCG_23404 GPA2 ZSIG51 |
Description | FUNCTION: Functions as a heterodimeric glycoprotein hormone with GPHB5 able to bind and activate the thyroid-stimulating hormone receptor (TSHR), leading to increased cAMP production . Plays a central role in controlling thyroid cell metabolism . . |
Accessions | ENST00000533257.1 ENST00000279168.7 Q96T91 ENST00000532246.1 E9PLQ0 A0A024R579 |